Patentanwältin / German Patent Attorney
European Trademark and Design Attorney
Technical Expertise: Pharmacy, Pharmacology, Molecular Biology, Biochemistry
Dr. Svenja Dorothea Steinbrink is admitted before the German Patent and Trademark Office, the German Federal Patent Court and the European Union Intellectual Property Office. She was trained in the firm of Zwicker Schnappauf & Partner Patentanwälte PartG mbB.
Svenja Dorothea’s area of practice is drafting and prosecution of German, European, and international patent applications. Further, she assists the attorneys of the firm Zwicker Schnappauf & Partner Patentanwälte PartG mbH in opposition, infringement, and nullity proceedings of German and European patents.
Svenja Dorothea studied Pharmacy at the Goethe University, Frankfurt and the University of Hamburg, Germany. In her practical year, she worked at Schützen-Pharmacy in Munich and at the Institute of Pharmacy of the Otago University, Dunedin, New Zealand, where she completed with the Postgraduate Certificate in Pharmacy.
Svenja Dorothea conducted research towards a Ph.D. with Prof. Dr. Dieter Steinhilber at the Institute of Pharmaceutical Chemistry at Goethe University, Frankfurt. The Ph.D. was followed by postdoctoral research in the same group for another 1,5 years. Accompanying her Ph.D. thesis she studied law where she focused on the area of Intellectual Property.
Svenja Dorothea holds a masters degree of the University of Marburg in pharmaceutical law. Her master thesis deals with the prevailing topic of second medical use claims: scope and infringement.
In 2018, Svenja worked in the IP group of a large Boston-based law firm where she gained a deep understanding of US patent prosecution.
Since 2013, Svenja Dorothea is holding a lectureship within the program of the Graduation School (GRADE) of Goethe University Frankfurt. She is member of the Advisory Board of the INNOVECTIS Technology Transfer Center of Goethe University Frankfurt since 2014. Svenja is a member of the German Association for the Protection of Intellectual Property (GRUR), of the Licensing Executive Society (LES) and of the German Pharmaceutical Society (DPhG).